Clinical- and Economic-performance of Ledipasvir and Sofosbuvir for HCV Genotype 1 in New York City: $ 100,000 per SVR12
Kian Bichoupan,Daniel J. Waintraub,Neal M. Patel,Sweta Chekuri,Joshua Hartman,Alyson Harty, David B. Motamed,Alicia Stivala,Viktoriya Khaitova,Angela Woody,Meena B. Bansal,Priya Grewal,Ritu Agarwal,Charissa Y. Chang,Jennifer Leong,Gene Y. Im,Lawrence Liu,Joseph A. Odin,Nancy Bach,Scott L. Friedman,Thomas D. Schiano,Ponni V. Perumalswami,Albert Min,Lan S. Wang,Jahnavi Naik,Douglas Dieterich,Andrea D. Branch HEPATOLOGY(2015)
AI 理解论文
溯源树
样例